Key Takeaways:
- Apple Watch can now alert users to possible high blood pressure.
- Alerts use 30-day heart data, not exact cuff readings.
- FDA approval clears global rollout to 150+ countries.
Apple is once again expanding the role of its smartwatch in healthcare. Beginning this month, millions of Apple Watch owners around the world will gain access to a groundbreaking feature: FDA-cleared hypertension alerts. The update, included with the release of watchOS 26, allows certain models of the Apple Watch to screen for signs of chronic high blood pressure—often called the “silent killer.”
Why Hypertension Matters
Hypertension, or high blood pressure, occurs when the force of blood against artery walls is consistently too high. Left untreated, it can lead to serious health problems such as heart attacks, strokes, and kidney disease. The World Health Organization estimates that 1.3 billion adults worldwide live with hypertension, and nearly half don’t know they have it because symptoms rarely show up until complications occur.
In the United States, nearly one in two adults are affected, making early detection a pressing public health challenge. Apple believes its new alerts could notify over one million people in the first year alone who may be living with undiagnosed hypertension.
How the Alerts Work
The Apple Watch doesn’t replace a blood pressure cuff, nor does it give exact systolic or diastolic readings. Instead, it uses its optical heart sensor to measure blood volume changes through the skin—a technique known as photoplethysmography (PPG). Over time, the watch passively collects this data while filtering for moments when the user is sitting still.
A machine-learning algorithm then reviews the readings in 60-second segments, compiling data over a rolling 30-day period. If it detects consistent patterns that suggest hypertension, the watch issues a discreet alert. Users are then advised to:
- Record their blood pressure for seven days using a standard cuff.
- Share those results with a healthcare provider.
This process aligns with guidelines from the American Heart Association, ensuring the watch is used as a screening tool rather than a diagnostic device.
Backed by Research and FDA Clearance
Apple’s hypertension detection system isn’t arriving overnight. It was developed using data from more than 100,000 participants across multiple studies and validated in a clinical trial of over 2,000 people. The U.S. Food and Drug Administration cleared the feature on Sept. 11, 2025, confirming its safety and reliability.
Unlike competitors who’ve faced pushback for launching unapproved health features, Apple pursued FDA review early, helping to build trust among healthcare professionals and users alike.
Who Can Use It
The feature will be available on:
- Apple Watch Series 9, Series 10, and the new Series 11
- Apple Watch Ultra 2 and the new Ultra 3
These devices must be running watchOS 26, which rolls out Sept. 15 for existing models. The Series 11 and Ultra 3 will ship with the feature enabled starting Sept. 19.
The alerts will launch in over 150 countries, including the U.S. and Europe, though some regions may require additional regulatory clearance.
There are some exclusions: the alerts are not intended for people under 22, individuals who are pregnant, or anyone already diagnosed with hypertension.
Benefits for Everyday Users
For many, the biggest advantage is awareness. Because hypertension usually has no warning signs, an early alert may prompt users to seek medical help sooner. This can lead to lifestyle changes—such as diet, exercise, or stress management—or medical treatment before serious complications develop.
The watch’s integration with the Health app also means users can easily track their trends, log cuff readings, and share data directly with doctors, encouraging a more collaborative approach to care.
Limitations and What’s Next
It’s important to note that the watch won’t catch every case of hypertension. Its alerts depend on consistent data collection, and confirmation with a cuff is still required. Accessibility to reliable home blood pressure monitors may also pose challenges in some communities.
Still, the rollout represents a major step toward preventative healthcare. And Apple isn’t stopping here—reports suggest the company is already exploring ways to deliver precise blood pressure readings directly from the watch, which could someday eliminate the need for an external cuff altogether.
A New Role for Wearables
The Apple Watch has long tracked activity, heart rate, and even sleep. With the addition of hypertension alerts, it’s stepping further into the realm of proactive healthcare. For those at risk, it could serve as an early warning system—and for the broader public, it marks another example of technology bridging the gap between everyday life and lifesaving healthcare.
As Apple rolls out this new tool, the message is clear: sometimes, the most important alerts aren’t texts or emails—they’re the ones that may save your life.